Pharmaceutical manufacturer IDT Australia has reported revenue for the quarter ended 30 September up 70 percent on the previous corresponding period to reach a two year high of $5.2 million. The Melbourne company said the results were encouraging and came on top of the it submitting proposals worth $24.7 million and securing $6.8 million in…
Psychotropic medicines manufacturer Mynd Bio Pty Ltd has made a surprise bid to acquire listed pharmaceutical developer, Melbourne-based IDT Australia. The bidder is part of a larger group which has already invested in a group of pharmaceutical companies that develop psychotropic medicines, planning to set up manufacturing in Portugal to tackle the European market. The…
The Victorian government has announced backing for pharmaceutical manufacturer IDT Australia to boost production of live-saving cancer treatments. IDT Australia will build a new facility in Boronia, Melbourne to manufacture Antibody Drug Conjugates (ADCs) which have the specificity of monoclonal antibodies and deliver chemotherapy agents to cancer tumor sites. ADCs are set to replace almost…
By Peter Roberts Companies have begun to receive belated notices from the federal government that their applications for grant support under the Morrison government’s Modern Manufacturing Initiative, with IDT Australia one that has opted for a full strategic review following news its bid for a MMI grant had failed. Industry minister Ed Husic this week…
While Canberra has announced an ‘in-principal’ agreement with US company Moderna to manufacture mRNA vaccines in Victoria, Melbourne pharmaceutical and vaccine manufacturer IDT Australia has announced it has been informed that it has missed out on government support. The company said today it was disappointed that its proposal to establish mRNA manufacturing in response to…
Pharmaceutical manufacturer and clinical trials group IDT Australia (ASX: IDT) is confident of better times ahead following a flat 2019 which saw revenue down on the previous year. The company, which manufactures pharmaceutical active ingredient and consumer dosage products, as well as conducting clinical trials, has recovered from an adverse situation with the US FDA…
Listed pharmaceutical company IDT Australia (ASX:IDT) has gained a Medical Cannabis Manufacturing Licence from the Office of Drug Control.
By Brian Schmidt, Australian National University This article is part of our series on big ideas for the Universities Accord. The federal government is calling for ideas to “reshape and reimagine higher education, and set it up for the next decade and beyond”. A review team is due to finish a draft report in June…
Do you have what it takes to be named as one of Australia’s top 50 in @AuManufacturing’s annual Australia’s 50 Most Innovative Manufacturers campaign? @AuManufacturing news is again looking to identify and celebrate Australia’s 50 most innovative manufacturers. Nominees are assessed by an expert panel, are selected for a shortlist, are profiled by our editors…
Australia’s manufacturing industry will have to continue to forge ahead alone as the government response remains light on details and lack clarity in helping the industry remain resilient. Here, Sandy Plunkett highlights the government’s glaring gaps and lack of commitment to Australia’s advanced manufacturing. The primary takeaway from the Federal government’s long-awaited response to last…
